A first step towards preventive medicine in multiple sclerosis

Nature Reviews Neurology, Published online: 05 January 2023; doi:10.1038/s41582-022-00769-9The results of the first randomized, placebo-controlled trial of dimethyl fumarate in a cohort of participants with radiologically isolated syndrome showed efficacy against the risk of a first clinical demyelinating event. The findings pave the way for preventive medicine in multiple sclerosis and highlight the need for more precise prognostication of risk.
Source: Nature Reviews Neurology - Category: Neurology Authors: Source Type: research